BioCryst Pharmaceuticals Inc (BCRX)
5.325
-0.02
(-0.28%)
USD |
NASDAQ |
May 10, 16:00
5.325
0.00 (0.00%)
After-Hours: 18:43
BioCryst Pharmaceuticals Gross Profit (Quarterly): 91.37M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 91.37M |
December 31, 2023 | 91.76M |
September 30, 2023 | 85.61M |
June 30, 2023 | 81.54M |
March 31, 2023 | 67.84M |
December 31, 2022 | 77.05M |
September 30, 2022 | 72.21M |
June 30, 2022 | 65.28M |
March 31, 2022 | 49.68M |
December 31, 2021 | 46.74M |
September 30, 2021 | 40.38M |
June 30, 2021 | 49.62M |
March 31, 2021 | 13.14M |
December 31, 2020 | 3.935M |
September 30, 2020 | 4.576M |
June 30, 2020 | 2.871M |
March 31, 2020 | 4.754M |
December 31, 2019 | 37.15M |
September 30, 2019 | 1.757M |
June 30, 2019 | 1.422M |
March 31, 2019 | 4.401M |
December 31, 2018 | 2.659M |
September 30, 2018 | 1.436M |
June 30, 2018 | 12.25M |
March 31, 2018 | 3.836M |
Date | Value |
---|---|
December 31, 2017 | 3.761M |
September 30, 2017 | 7.503M |
June 30, 2017 | 3.077M |
March 31, 2017 | 9.143M |
December 31, 2016 | 6.531M |
September 30, 2016 | 7.62M |
June 30, 2016 | 4.76M |
March 31, 2016 | 4.743M |
December 31, 2015 | 4.574M |
September 30, 2015 | 9.636M |
June 30, 2015 | 25.40M |
March 31, 2015 | 6.751M |
December 31, 2014 | 5.402M |
September 30, 2014 | 3.238M |
June 30, 2014 | 1.461M |
March 31, 2014 | 3.385M |
December 31, 2013 | 10.55M |
September 30, 2013 | 2.389M |
June 30, 2013 | 0.817M |
March 31, 2013 | 3.477M |
December 31, 2012 | 4.083M |
September 30, 2012 | 5.647M |
June 30, 2012 | 4.21M |
March 31, 2012 | 12.22M |
December 31, 2011 | 5.224M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
1.422M
Minimum
Jun 2019
91.76M
Maximum
Dec 2023
44.43M
Average
48.18M
Median
Gross Profit (Quarterly) Benchmarks
Integra Lifesciences Holdings Corp | 206.83M |
Krystal Biotech Inc | 42.83M |
AIM ImmunoTech Inc | 0.053M |
Protalix BioTherapeutics Inc | 1.63M |
Armata Pharmaceuticals Inc | -- |